APA

Infusini G., Smith J. M., Yuan H., Pizzolla A., Ng W. C., Londrigan S. L., Haque A., Reading P. C., Villadangos J. A. & Wakim L. M. (20160620). Respiratory DC Use IFITM3 to Avoid Direct Viral Infection and Safeguard Virus-Specific CD8+ T Cell Priming. : PloS one.

Chicago

Infusini Giuseppe, Smith Jeffrey M, Yuan He, Pizzolla Angela, Ng Wy Ching, Londrigan Sarah L, Haque Ashraful, Reading Patrick C, Villadangos Jose A and Wakim Linda M. 20160620. Respiratory DC Use IFITM3 to Avoid Direct Viral Infection and Safeguard Virus-Specific CD8+ T Cell Priming. : PloS one.

Harvard

Infusini G., Smith J. M., Yuan H., Pizzolla A., Ng W. C., Londrigan S. L., Haque A., Reading P. C., Villadangos J. A. and Wakim L. M. (20160620). Respiratory DC Use IFITM3 to Avoid Direct Viral Infection and Safeguard Virus-Specific CD8+ T Cell Priming. : PloS one.

MLA

Infusini Giuseppe, Smith Jeffrey M, Yuan He, Pizzolla Angela, Ng Wy Ching, Londrigan Sarah L, Haque Ashraful, Reading Patrick C, Villadangos Jose A and Wakim Linda M. Respiratory DC Use IFITM3 to Avoid Direct Viral Infection and Safeguard Virus-Specific CD8+ T Cell Priming. : PloS one. 20160620.